We also found the activation of immune response in these subclusters and revealed TCL1A+ naïve B, DUSP4+ Atm, and MZB1+ PC as favorable prognostic factors for patients with HNSCC. This evidence concerns the gene MZB1 and head and neck squamous cell carcinoma.